-+ 0.00%
-+ 0.00%
-+ 0.00%

Kleiman Rajaram and Phillips & Cohen Announce Successful $46 Million Qui Tam Action Against Veloxis Pharmaceuticals

Barchart·08/15/2026 05:40:00
Listen to the news

Veloxis Admits to Kickbacks, and to Pay Criminal Fines and Civil Penalties

BOSTON, Aug. 15, 2026 /PRNewswire/ -- In a major healthcare fraud enforcement action, Veloxis Pharmaceuticals will pay over million and accept a stringent deferred prosecution agreement after admitting illegal conduct tied to Envarsus XR in a case brought by two leading qui tam firms, Kleiman Rajaram and Phillips & Cohen.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.